U.S. Regulators Give Full Approval to Pfizer COVID-19 Vaccine

The video discusses the first vaccine to receive full approval in the US, moving beyond emergency use status. This approval comes amid the spread of the Delta variant, with the vaccine showing 91% effectiveness in preventing infection. The full license applies to those 16 and older, while emergency use continues for ages 12 to 15. A poll indicates that full approval may increase vaccination rates among the unvaccinated.

What new insight or understanding did you gain from this video?